Advertisement
UK markets close in 19 minutes
  • FTSE 100

    8,040.00
    -4.81 (-0.06%)
     
  • FTSE 250

    19,712.77
    -86.95 (-0.44%)
     
  • AIM

    754.42
    -0.45 (-0.06%)
     
  • GBP/EUR

    1.1635
    +0.0007 (+0.06%)
     
  • GBP/USD

    1.2438
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    52,334.14
    -1,400.52 (-2.61%)
     
  • CMC Crypto 200

    1,407.87
    -16.23 (-1.14%)
     
  • S&P 500

    5,061.29
    -9.26 (-0.18%)
     
  • DOW

    38,373.02
    -130.67 (-0.34%)
     
  • CRUDE OIL

    82.76
    -0.60 (-0.72%)
     
  • GOLD FUTURES

    2,346.90
    +4.80 (+0.20%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,079.36
    -58.29 (-0.32%)
     
  • CAC 40

    8,084.71
    -21.07 (-0.26%)
     

IDEX Biometrics 2021 Annual Report on Form 20-F

IDEX BIOMETRICS ASA
IDEX BIOMETRICS ASA

IDEX Biometrics’ 2021 annual report on form 20-F has been filed with the U.S. Securities and Exchange Commision (SEC). The report is enclosed (link below).

The file is also available at the company’s web site www.idexbiometrics.com. All SEC filings by IDEX Biometris are available from the SEC's website at www.sec.gov.

For further information contact:
Marianne Bøe, Head of Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: +47 918 00186

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

ADVERTISEMENT

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics


This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment